IP Library Granted Patent US 8,258,142
Granted Patent B2
US 8,258,142 · App. 12/967,876 · Granted Sep 4, 2012

Substituted 8-[6-amino-3-pyridyl]xanthines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,258,142
App. No.
12/967,876
Granted
Sep 4, 2012
Kind
B2
Abstract

The present invention provides substituted 8-[6-amino-3-pyridyl]xanthines such as the following: and pharmaceutical compositions that are selective antagonists of A 2B adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.

Claims (8)

1. A compound selected from the group:

or a pharmaceutically acceptable salt thereof.

2. A pharmaceutical composition comprising:

(a) a therapeutically effective amount of compound 50 or 51 of claim 1 ; and

(b) a pharmaceutically acceptable excipient.

3. A method for inhibiting the activity of Adenosine A 2B receptors in a mammal comprising administering to the mammal an effective amount of compound 50 or 51 of claim 1 .

4. A method for treating asthma comprising administering an effective amount of compound 50 or 51 of claim 1 to a mammal in need of such treatment.

5. A method for treating diabetic retinopathy comprising administering an effective amount of compound 50 or 51 of claim 1 or a pharmaceutically acceptable salt thereof to a mammal in need of such treatment.

Assignments (8)
MERGER Recorded Jun 26, 2018
From: DOGWOOD PHARMACEUTICALS, INC.
To: ALLERGAN SALES, LLC
Reel/Frame 046208/0691 →
CORRECTIVE ASSIGNMENT TO CORRECT THE EXECUTION DATE OF THE PREVIOUSLY RECORDED ASSIGNMENT FROM DECEMBER 31, 2011 TO MARCH 15, 2013 PREVIOUSLY RECORDED ON REEL 029737 FRAME 0569. ASSIGNOR(S) HEREBY CONFIRMS THE EXECUTION DATE OF THE ORIGINAL ASSIGNMENT DATED ON DECEMBER 31, 2011 WAS INCORRECT. Recorded Mar 19, 2013
From: FOREST LABORATORIES HOLDINGS LIMITED
To: DOGWOOD PHARMACEUTICALS, INC.
Reel/Frame 030045/0899 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2013
From: DOGWOOD PHARMACEUTICALS, INC.
To: FOREST LABORATORIES HOLDINGS LIMITED
Reel/Frame 029737/0498 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2013
From: CLINICAL DATA, INC.
To: DOGWOOD PHARMACEUTICALS, INC.
Reel/Frame 029737/0389 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2013
From: FOREST LABORATORIES HOLDINGS LIMITED
To: DOGWOOD PHARMACEUTICALS, INC.
Reel/Frame 029737/0569 →
MERGER Recorded Jan 31, 2013
From: TROVIS PHARMACEUTICALS LLC
To: TROVIS PHARMACEUTICALS HOLDINGS, INC.
Reel/Frame 029728/0400 →
MERGER Recorded Jan 31, 2013
From: TROVIS PHARMACEUTICALS HOLDINGS, INC.
To: CLINICAL DATA, INC.
Reel/Frame 029728/0445 →
CHANGE OF NAME Recorded Jan 28, 2011
From: PGXHEALTH, LLC
To: TROVIS PHARMACEUTICALS, LLC
Reel/Frame 025709/0994 →